
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en-us">
<head id="ctl00_ctl00_Head1"><script id="EktronJS" type="text/javascript" src="/WorkArea/java/ektron.js"></script><script id="EktronRegisteredJs" type="text/javascript" src="/workarea/java/ektronJs.ashx?id=EktronFlexMenuJS"></script><script id="AjaxScript" type="text/javascript" src="/WebResource.axd?d=2pxveDD0BARjSOs4izlAg8tHAkCeTn7ZFXo2l4hI4Yrr6KDY58mVoTfnFcfiGOp3S8RTiYa5VT8gntFqXpkCrAceGxwozsS9p_gMiassQloJMIZepSyrLFaEjvx794PwOvQmgQ2&amp;t=634246524294535000"></script><script id="EktronMessageBoardJs" type="text/javascript" src="/WorkArea/java/MessageBoard.js"></script><script id="EktronRegisteredJs2" type="text/javascript" src="/workarea/java/ektronJs.ashx?id=EktronModalJS"></script><link id="EktronRegisteredCss" rel="stylesheet" type="text/css" href="/workarea/csslib/ektronCss.ashx?id=EktronModalCss+EktronCssMessageboard" /><meta name="Keywords" content="Oxford Nanopore; Illumina; nanopore war; next-generation sequencing; NGS" />
<meta name="Description" content="Breaking a near total vow of silence after three years in stealth mode, Oxford Nanopore has offered stunning details of its nanopore next-generation sequencing (NGS) technology to a packed house at the premier genome sequencing conference in Marco Island, Florida.      In a talk at the Advances in Genome Biology and Technology conference this morning, chief technology officer Clive Brown presented details of what the British company calls its “new generation” of single-strand sequencing technology, featuring accurate long reads of single-stranded DNA molecules, including the completion of two viral genomes.      In the second half of this year, the company will commercially release its previously announced GridION instrument, or node, as well as the world’s smallest DNA sequencing instrument – a portable cartridge called the MinION that doubles (and works as) a USB drive.      And in a presentation that only briefly indulged in marketing hype, Brown laid out the prospect of achieving the $1,000 genome in 2013 in under an hour by harnessing 20 GridION nodes working with a second-generation nanopore array." />
<meta property="og:image" content="/template_images/BioIT/Bio-ITWorld-og.jpg" /><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><title>
	Oxford Strikes First in DNA Sequencing Nanopore Wars - Bio-IT World
</title><link rel="stylesheet" type="text/css" href="/Stylesheets/Reset.css" />
<link rel="stylesheet" type="text/css" href="/Stylesheets/main.css" />
<link rel="stylesheet" type="text/css" href="/Stylesheets/noprint.css" media="print" />
<link rel="'stylesheet'" type="'text/css'" href="'http://fonts.googleapis.com/css?family=Droid+Sans:400,700'" />
<script language="javascript" type="text/javascript" src="/Javascript/basic.js"></script><script language="javascript" type="text/javascript" src="/Javascript/swfobject.js"></script><link rel="shortcut icon" type="image/x-icon" href="/template_images/BioIT/favicon.ico" />
<link rel="stylesheet" type="text/css" href="/Stylesheets/bit-slider-default.css" media="screen" />
<link rel="stylesheet" type="text/css" href="/Stylesheets/bit-slider.css" media="screen" />
<link rel="stylesheet" type="text/css" href="/Stylesheets/bit-slider-style.css" media="screen" />
<link rel="stylesheet" type="text/css" href="/Stylesheets/bioitdig.css" />
<link rel="stylesheet" type="text/css" href="/stylesheets/themes/bioit/jquery-ui-1.8.18.custom.css" />
<link rel="stylesheet" type="text/css" href="/Stylesheets/shadowbox.css" />
<script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.5/jquery.min.js"></script><script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jqueryui/1.8/jquery-ui.min.js"></script><script type="text/javascript" src="/Javascript/jquery.watermark.js"></script><script type="text/javascript"><!--
$(document).ready(function () {
            $("#accordion").accordion();
            $("#accordion").accordion("option", "clearStyle", true);
            $("#accordion").accordion("option", "icons", false);
            $(".SearchTextAndButton input[type='text']").watermark("Search");
            $("#ctl00_ctl00_cphContent_cphContent_ContentBlock_MainContent font").attr("face","").attr("size","");
        });
--></script><script language="javascript" type="text/javascript" src="/tweet/jquery.tweet.js"></script><link rel="stylesheet" type="text/css" href="/tweet/jquery.tweet.css" media="all" />
<script type="text/javascript"><!--
jQuery(function ($) {
            $(".tweet").tweet({
                username: "bioitworld",
                join_text: "auto",
                avatar_size: 32,
                count: 2,
                auto_join_text_default: "",
                auto_join_text_ed: "",
                auto_join_text_ing: "",
                auto_join_text_reply: "",
                auto_join_text_url: "",
                loading_text: "loading tweets..."
            });
        });
--></script><script type="text/javascript"><!--
$(function () {
                $("#tabs").tabs();
            });
--></script><script type="text/javascript" src="/Javascript/bit/jqChromelessYoutube.js"></script><script type="text/javascript" src="http://platform.linkedin.com/in.js"></script><script type="text/javascript"><!--
function onLinkedInLoad() {
            IN.Event.on(IN, "auth", onLinkedInAuth);
        }

        function onLinkedInAuth() {
            IN.API.Raw("/groups/3141702:(id,name,short-description,relation-to-viewer:(membership-state),site-group-url,num-members)").result(function groupCallback(result) {
                $("LinkedInGroup").append(result);
            });
        }
--></script><script type="text/javascript"><!--
function loadData() {
            $("button").click(function () {
                JoinGroup();
            });

        }

        function JoinGroup() {
            IN.API.Raw("people/~/group-memberships/3141702")
           .method("PUT")
           .body(JSON.stringify({ "membershipState": { "code": "member"} }))
           .result(function (result) { alert("Group Joined") }).
           error(function (result) {
               alert(JSON.stringify(result));
           });
        }
--></script><script type="text/javascript"><!--
$(function () {
            $("#tabs").tabs();
        });
--></script><script type="text/javascript" src="/Javascript/shadowbox.js"></script><script type="text/javascript"><!--
Shadowbox.init({
            // let's skip the automatic setup because we don't have any
            // properly configured link elements on the page
            displayNav: true
        });
--></script><script type="text/javascript" src="/Javascript/jcarousel.js"></script><script type="text/javascript"><!--
jQuery(document).ready(function () {
             jQuery('#ctl00_cphContent_BioITRelatedProduct1_mycarousel').jcarousel({
                 visible: 4
             });

             loadAds();
         });
--></script><script type="text/javascript" src="/Javascript/jquery.ba-jqmq.js"></script><script type="text/javascript" src="/Javascript/jquery.ba-loadadscript.js"></script><script type="text/javascript"><!--
adRotation = 900000;
        axel = Math.random() + "";
        ord = axel * 1000000000000000000;
        ordStr = ord + "?";
        var interstitialLoaded = 0;

        function loadAds() {
            axel = Math.random() + "";
            ord = axel * 1000000000000000000;
            ordStr = ord + "?";

            Ads('.AdLeaderBoardTop', 'http://ad.doubleclick.net/adj/site169.tmus;tile=1;sz=728x90;ord=' + ordStr);
            Ads('.AdLeaderBoardButton', 'http://ad.doubleclick.net/adj/site169.tmus;tile=1;sz=234x60;ord=' + ordStr);
            Ads('.AdIMU', 'http://ad.doubleclick.net/adj/site169.tmus;tile=1;sz=336x280,300x250;ord=' + ordStr);
            Ads('.AdSky', 'http://ad.doubleclick.net/adj/site169.tmus;dcopt=ist;abr=!webtv;sz=120x600,150x800,160x600,150x600;ord=' + ordStr);
            Ads('.AdButton1', 'http://ad.doubleclick.net/adj/site169.tmus;tile=1;sz=160x160;ord=' + ordStr);
            Ads('.AdButton2', 'http://ad.doubleclick.net/adj/site169.tmus;tile=2;sz=160x160;ord=' + ordStr);
            Ads('.AdButton3', 'http://ad.doubleclick.net/adj/site169.tmus;tile=3;sz=160x160;ord=' + ordStr);
 

if( window.location.pathname != "/") {
    Ads('.AdIMU2', 'http://ad.doubleclick.net/adj/site169.tmus;tile=2;sz=336x280,300x250;ord=' + ordStr);
    Ads('.AdButton4', 'http://ad.doubleclick.net/adj/site169.tmus;tile=4;sz=160x160;ord=' + ordStr);
    // Ads('.AdButton5', 'http://ad.doubleclick.net/adj/site169.tmus;tile=5;sz=160x160;ord=' + ordStr);
} else {
  $(".AdIMU2").hide();
  $(".AdButton4").hide();
}
            Ads('.AdLeaderBoardBottom', 'http://ad.doubleclick.net/adj/site169.tmus;tile=2;sz=728x90;ord=' + ordStr);
            Ads('.BottomAdRight', 'http://ad.doubleclick.net/adj/site169.tmus;tile=2;sz=234x60;ord=' + ordStr);

            // Mike Croft
            // Date: 10/3/2013
            // Commented since we're not running flash ads.  If we run a flash IMU, we may need this code. 
            //$("#AdIMU").text = '';
            //if ($("#HiddenIMU a").length) {
            //    $("#HiddenIMU a").appendTo("#AdIMU");
            //} else if ($("#HiddenIMU object").length) {
            //    $("#HiddenIMU object").appendTo("#AdIMU");
            //}

   
            window.setTimeout(loadAds, adRotation);
        }
--></script><script type="text/javascript"><!--
function Ads(divClass, Adscript) {

            $(divClass).fadeOut('slow', function () {
                $(divClass).text('');
                $(divClass).loadAdScript(Adscript);
            });
            $(divClass).fadeIn('slow');
        }
--></script><script type="text/javascript"><!--
$(document).ready(function () {
            var yplayer = $("#ytplayer").get(0);
            $(".featuredVideoContent a").click(function () {
                _gaq.push(['_setAccount', 'UA-912037-7'], ['_setDomainName', 'www.bio-itworld.com'], ['_trackEvent', 'Featured Video', 'Click', encodeURI($(this).children("img").attr('title').replace(/ +/g,'-'))]);
                Shadowbox.open({
                    content: $(this).closest(".featuredVideoContent").children("#videoHtml").html(),
                    player: "html",
                    title: $(this).children("img").attr("title"),
                    height: 360,
                    width: 640,
                    onClose: function () {
                        yplayer.stopVideo();
                    }
                });
                return false;
            });

$("a.hlVideo").click(function () {
    var title = $(this).children("img").attr("title");
    _gaq.push(['_setAccount', 'UA-912037-7'], ['_setDomainName', 'www.bio-itworld.com'], ['_trackEvent', 'Featured Video', 'Click', encodeURI(title.replace(/ +/g,'-'))]);
                Shadowbox.open({
                    content: '<iframe width="560" height="315" src="' + $(this).attr("href") + '" frameborder="0" allowfullscreen></iframe>',
                    player: "html",
                    title: $(this).parent().children(".productName").children("a").html(),
                    height: 360,
                    width: 640,
                    onClose: function () {
                        yplayer.stopVideo();
                    }
                });
                return false;
            });
        });
--></script><script type="text/javascript"><!--
var _gaq = _gaq || [];
        _gaq.push(['_setAccount', 'UA-23020641-16']);
        _gaq.push(['_trackPageview']);

        (function () {
            var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
            ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
            var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
        })();
--></script><script type="text/javascript" src="/Javascript/bit-slider-pack.js"></script><script type="text/javascript"><!--
$(window).load(function () {
            $('#slider').nivoSlider({
                effect: 'fade', // Specify sets like: 'fold,fade,sliceDown'
                slices: 15, // For slice animations
                boxCols: 8, // For box animations
                boxRows: 4, // For box animations
                animSpeed: 500, // Slide transition speed
                pauseTime: 3000, // How long each slide will show
                startSlide: 0, // Set starting Slide (0 index)
                directionNav: true, // Next & Prev navigation
                directionNavHide: true, // Only show on hover
                controlNav: true, // 1,2,3... navigation
                controlNavThumbs: false, // Use thumbnails for Control Nav
                controlNavThumbsFromRel: false, // Use image rel for thumbs
                controlNavThumbsSearch: '.jpg', // Replace this with...
                controlNavThumbsReplace: '_thumb.jpg', // ...this in thumb Image src
                keyboardNav: true, // Use left & right arrows
                pauseOnHover: true, // Stop animation while hovering
                manualAdvance: false, // Force manual transitions
                captionOpacity: 0.8, // Universal caption opacity
                prevText: 'Prev', // Prev directionNav text
                nextText: 'Next', // Next directionNav text
                randomStart: false, // Start on a random slide
                beforeChange: function () { }, // Triggers before a slide transition
                afterChange: function () { }, // Triggers after a slide transition
                slideshowEnd: function () { }, // Triggers after all slides have been shown
                lastSlide: function () { }, // Triggers when last slide is shown
                afterLoad: function () { } // Triggers when slider has loaded
            });
        });
--></script> <script type="text/javascript"><!--
$().ready( function() {
  $('#ctl00_cphContent_ContentBlock_SponsoredLinks a').click(function () {
    _gaq.push(['_setAccount', 'UA-912037-7'], ['_setDomainName', 'www.bio-itworld.com'], ['_trackEvent', 'Sponsored Link', 'Click', encodeURI($(this).attr('title').replace(/ +/g,'-'))]);
    window.open($(this).attr('href'));
    return false;
  }); 
  $('.featuredProduct a').click(function () {
    var title = $(".featuredProducts img").attr("title");
    _gaq.push(['_setAccount', 'UA-912037-7'], ['_setDomainName', 'www.bio-itworld.com'], ['_trackEvent', 'Featured Product', 'Click', encodeURI(title.replace(/ +/g,'-'))]);
    window.open($(this).attr('href'));
    return false;
  }); 
});
--></script><script type="text/javascript"><!--
$().ready( function() {
    $("#Barnett_Educational").hide();


   if ((window.location.pathname == '/' || window.location.pathname == '/bioit_homepage.aspx')) {
        var adStr = "<div id='hiddenAd' style='display: none;'>";
        adStr += "<div id='interstitialAd'>";
        adStr += "<A HREF='http://ad.doubleclick.net/N305762/jump/site169.tmus;sz=640x480;ord=" + ordStr + "'>";
        adStr += "<IMG id='interstitalImage' SRC='http://ad.doubleclick.net/N305762/ad/site169.tmus;sz=640x480;ord=" + ordStr + "' BORDER=0 WIDTH=640 HEIGHT=480 ALT='Advertisement'></A>";
        adStr += "  </div>";
        adStr += "</div>";

        $(adStr).appendTo("body");

        $("#interstitalImage").bind("load", function () {
            Shadowbox.open({
                content: $("#interstitialAd").html(),
                player: "html",
                title: '',
                height: 500,
                width: 660
            });
            interstitialLoaded = 1;
            setTimeout(function () {
                Shadowbox.close();
            }, 7000);
        });
    }

});
--></script><link rel="stylesheet" href="/stylesheets/bit/carousel.css" media="screen" />
        <!--[if IE 7 ]> 
    <html class="ie ie7" dir="ltr" lang="en-US">
<![endif]-->
<!--[if IE 8]>
    <html class="ie ie8" lang="en-US">
<![endif]-->
    <!--[if lt IE 9]>
    <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script>
    <![endif]-->
<meta name="Keywords" content="Oxford Nanopore;Illumina;nanopore war;next-generation sequencing;NGS" /><meta name="Description" content="Breaking a near total vow of silence after three years in stealth mode, Oxford Nanopore has offered stunning details of its nanopore next-generation sequencing (NGS) technology to a packed house at the premier genome sequencing conference in Marco Island, Florida. 

 In a talk at the Advances in Genome Biology and Technology conference this morning, chief technology officer Clive Brown presented details of what the British company calls its “new generation” of single-strand sequencing technology, featuring accurate long reads of single-stranded DNA molecules, including the completion of two viral genomes. 

 In the second half of this year, the company will commercially release its previously announced GridION instrument, or node, as well as the world’s smallest DNA sequencing instrument – a portable cartridge called the MinION that doubles (and works as) a USB drive. 

 And in a presentation that only briefly indulged in marketing hype, Brown laid out the prospect of achieving the $1,000 genome in 2013 in under an hour by harnessing 20 GridION nodes working with a second-generation nanopore array." /><base href="http://www.bio-itworld.com/" /></head>
    
</head>
<body>
    <form name="aspnetForm" method="post" action="/news/02/17/12/oxford-strikes-first-in-dna-sequencing-nanopore-wars.html" id="aspnetForm">
<div>
<input type="hidden" name="ctl00_ctl00_ScriptManager1_HiddenField" id="ctl00_ctl00_ScriptManager1_HiddenField" value="" />
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" />
</div>


<script src="/ScriptResource.axd?d=u8-Mki1UIk06dClhycivxVm_2403JpHg7f6aocVgnoK3PsGBwRgIK-Ir0mqBFCiNAZIXKUU9Oy5-VOMCbiCnPBt3c89qn-5tNPuFi1FXcg4HU4lI0&amp;t=4a89e84f" type="text/javascript"></script>
<div>

	<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEWAgKb1/znDQKG4P/UAg==" />
</div>
    <div style="width: 1000px; margin: auto; position: relative; background-color: #fff;">
        
        <!-- Begin Header-->
        <div class="AdLeaderBoardSocial">
          <div class="Abstract" style="color: white;"><a title="YouTube" href="http://www.youtube.com/bioitworld" target="_blank"><img title="YouTube" style="padding-right: 5px; padding-top: 5px;" alt="YouTube" src="http://chicorporate.com/template_images/social-media-icons/youtube.png" border="0" /></a> <a title="Facebook" href="http://www.facebook.com/bioitworld" target="_blank"><img title="Facebook" style="padding-right: 5px; padding-top: 5px;" alt="Facebook" src="/template_images/social-media-icons/facebook.png" border="0" /></a> <a title="LinkedIn" href="http://www.linkedin.com/groupRegistration?gid=3141702" target="_blank"><img title="LinkedIn" style="padding-right: 5px; padding-top: 5px;" alt="LinkedIn" src="/template_images/social-media-icons/linkedin.png" border="0" /></a> <a title="Google+" href="https://plus.google.com/+Bio-itworld" target="_blank" rel="publisher"><img title="Google+" style="padding-top: 5px; padding-right: 5px;" alt="Google+" src="/template_images/social-media-icons/gplus2.png" border="0" /></a> <a title="Twitter" href="http://twitter.com/bioitworld" target="_blank"><img title="Twitter" style="padding-top: 5px; padding-right: 5px;" alt="Twitter" src="/template_images/social-media-icons/twitter.png" border="0" /></a> <a title="Xing" href="http://www.xing.com/net/bioitworld" target="_blank"><img title="xing" style="padding-top: 5px; padding-right: 5px;" alt="Xing" src="/template_images/social-media-icons/xing.png" border="0" /></a><a title="rss" href="/RSS/BioIT_WorldNews_RSS.aspx" target="_blank"><img title="rss" style="padding-top: 5px;" alt="rss" src="/template_images/social-media-icons/rss.png" border="0" /></a>

&#160;</div>

        </div>
        <div class="chi_logo">
            <img src="/template_images/BioIT/chi.jpg" width="217px" height="41px" border="0" />
        </div>
          <div id="nav2">
                    <ul>
                        <li><a href="http://www.chicorporate.com">CHI home</a></li>
                        <li><a href="http://www.chicorporate.com/Corporate/AboutUs.aspx">about</a></li>
                        <li><a href="http://www.chicorporate.com/Corporate/ContactUs.aspx">contact us</a></li>
                        <li><a href="http://www.chicorporate.com/Corporate/RequestInformation.aspx">request
                            info</a></li>
                    </ul>
                </div>
        <div class="TopAds NoPrint">
            <div class="AdLeaderBoardButton">
                 
            </div>
            <div class="AdLeaderBoardTop">
                <div class="TopAdLeft">
                     
                </div>
            </div>
        </div>
        <div class="BioitPageTop" style="background-color: White;">
            <a title="Bio-IT World" href="/" id="Homepage"></a>
            <div class="logo">
            </div>
        </div>

   
        <!--End Header-->
        <!-- Content-->
        
    
    <div class="Content">
      <div class="navWrapper">
            <!-- start .row -->
                
                    <div id="navContainer">
                        <div id="ctl00_ctl00_cphContent_FlexMenu1">
	<ul id="nav" class="egNav_FlexMenu1"><li class=" egMenu_1655 egMenuLevel_0"><a class=" egMenuLevel_0" href="/BioIT/Subscribe.aspx" target="_self">Subscribe</a></li><li class=" egDrop egMenu_619 egMenuLevel_0"><a class=" egMenuLevel_0" href="/#">News</a><ul><li class=" egMenu_1657 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bioit_top_headlines.aspx" target="_self">Latest News</a></li><li class=" egMenu_1658 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bioit_Content.aspx?id=71480" target="_self">Archives</a></li><li class=" egMenu_1719 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bitw/pressreleases" target="_self">View Press Releases</a></li><li class=" egMenu_1720 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bitw/pressreleaseform" target="_self">Post a Press Release</a></li></ul></li><li class=" egDrop egMenu_620 egMenuLevel_0"><a class=" egMenuLevel_0" href="/#">Advertise</a><ul><li class=" egMenu_1660 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/Digital-Advertising" target="_self">Digital Advertising</a></li><li class=" egMenu_1661 egMenuLevel_1"><a class=" egMenuLevel_1" href="/uploadedFiles/Bio-IT_World/Whitepaper_SmartForms/Forms/PDF/Lead_Generation_CHI.pdf" target="_self">Lead Generation</a></li><li class=" egMenu_1662 egMenuLevel_1"><a class=" egMenuLevel_1" href="/uploadedFiles/CHI_MEDIA_GROUP/Assets/2014_BIT_Editorial_Calendar.pdf" target="_self">Editorial Calendar</a></li><li class=" egMenu_1773 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/Market-Surveys/" target="_self">Market Surveys</a></li><li class=" egMenu_1774 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/Webinars/" target="_self">Webinars</a></li><li class=" egMenu_1775 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/Whitepapers/" target="_self">Whitepapers</a></li><li class=" egMenu_1776 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/Podcasts/" target="_self">Podcasts</a></li><li class=" egMenu_1777 egMenuLevel_1"><a class=" egMenuLevel_1" href="/cmg_content.aspx?ekfrm=101212" target="_self">Media Kit</a></li><li class=" egMenu_1721 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bitw/pressreleases" target="_self">View Press Releases</a></li><li class=" egMenu_1722 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bitw/pressreleaseform" target="_self">Post a Press Release</a></li></ul></li><li class=" egDrop egMenu_621 egMenuLevel_0"><a class=" egMenuLevel_0" href="/#">Free Downloads</a><ul><li class=" egMenu_1664 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/Whitepapers.aspx" target="_self">Whitepapers</a></li><li class=" egMenu_1665 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/Podcasts.aspx" target="_self">Podcasts</a></li><li class=" egMenu_1666 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bio-it-webinars/" target="_self">Recorded Webinars</a></li><li class=" egMenu_1667 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT_Surveys.aspx" target="_self">Survey Results</a></li><li class=" egMenu_1668 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT-eBooks" target="_self">Inside eBooks</a></li></ul></li><li class=" egDrop egMenu_622 egMenuLevel_0"><a class=" egMenuLevel_0" href="/#">Careers</a><ul><li class=" egMenu_1670 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/JobOpenings.aspx" target="_self">View all Job Openings</a></li><li class=" egMenu_1671 egMenuLevel_1"><a class=" egMenuLevel_1" href="/BioIT/AddJobOpening.aspx" target="_self">Post a Job Opening</a></li></ul></li><li class=" egDrop egMenu_623 egMenuLevel_0"><a class=" egMenuLevel_0" href="/#">Product Directory</a><ul><li class=" egMenu_1673 egMenuLevel_1"><a class=" egMenuLevel_1" href="/Product-Directory" target="_self">View Product Directory</a></li><li class=" egMenu_1674 egMenuLevel_1"><a class=" egMenuLevel_1" href="/Product-Directory-Form" target="_self">Add Products</a></li></ul></li><li class=" egDrop egMenu_633 egMenuLevel_0"><a class=" egMenuLevel_0" href="/#">Events</a><ul><li class=" egMenu_1726 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bio-it-webinars" target="_self">Webinars</a></li><li class=" egMenu_1727 egMenuLevel_1"><a class=" egMenuLevel_1" href="/Featured_Events.aspx" target="_self">Industry Events</a></li></ul></li><li class=" egDrop egMenu_624 egMenuLevel_0"><a class=" egMenuLevel_0" href="/bioit_Content.aspx?id=137901">About Bio-IT World</a><ul><li class=" egMenu_1852 egMenuLevel_1"><a class=" egMenuLevel_1" href="/bioit_Content.aspx?id=137901" target="_self">Editorial Profile</a></li><li class=" egMenu_1677 egMenuLevel_1"><a class=" egMenuLevel_1" href="/uploadedFiles/CHI_MEDIA_GROUP/Assets/2014_BIT_Editorial_Calendar.pdf" target="_self">Editorial Calendar</a></li><li class=" egMenu_1678 egMenuLevel_1"><a class=" egMenuLevel_1" href="/contact-us.html" target="_self">Contact Us</a></li></ul></li></ul>
</div>
                        </div></div>
        <table class="ContentTable">
            <tr>
                <!--Left Column Content -->
                <td class="bioitContentLeft_sub NoPrint">
                    <div>
                        
    


    <div class="contentboxgrey">
        <div class="contentboxtext_red">
            <div class="RelatedStories">
                <div class="RelatedStoriesHeader maroonheader_left">RELATED STORIES</div>
                <div class="greysqlinks">
                <ul class="greysqlinks">
    
                    <li>
                    <div class="RelatedStory">
                        <a title="Big BRAIN: Finding Connections in the Literature Flood with Euretos BRAIN" href="/BioIT_Article.aspx?id=139575">Big BRAIN: Finding Connections in the Literature Flood with Euretos BRAIN</a> | Jul 01, 2014
                    </div>
                    </li>
    
                    <li>
                    <div class="RelatedStory">
                        <a title="FDA Loves Genetic Tests, If Accurate" href="/BioIT_Article.aspx?id=139567">FDA Loves Genetic Tests, If Accurate</a> | Jun 30, 2014
                    </div>
                    </li>
    
                    <li>
                    <div class="RelatedStory">
                        <a title="The Hunt for a New Human Reference Genome" href="/BioIT_Article.aspx?id=139549">The Hunt for a New Human Reference Genome</a> | Jun 30, 2014
                    </div>
                    </li>
    
                    <li>
                    <div class="RelatedStory">
                        <a title="Illumina Releases Long-Read Apps and Library Prep Kits" href="/BioIT_Article.aspx?id=139497">Illumina Releases Long-Read Apps and Library Prep Kits</a> | Jun 27, 2014
                    </div>
                    </li>
    
                    <li>
                    <div class="RelatedStory">
                        <a title="The UberCloud Experiment - Exploring Life Sciences in the Cloud" href="/BioIT_Article.aspx?id=139407">The UberCloud Experiment - Exploring Life Sciences in the Cloud</a> | Jun 25, 2014
                    </div>
                    </li>
    
                    <li>
                    <div class="RelatedStory">
                        <a title="Sequencing the Strange Communities: Taking on Metagenomics" href="/BioIT_Article.aspx?id=139337">Sequencing the Strange Communities: Taking on Metagenomics</a> | Jun 24, 2014
                    </div>
                    </li>
    
                    <li>
                    <div class="RelatedStory">
                        <a title="Australian Research Institute IDs Novel Syndrome Variants with NextCODE Tools" href="/BioIT_Article.aspx?id=139320">Australian Research Institute IDs Novel Syndrome Variants with NextCODE Tools</a> | Jun 23, 2014
                    </div>
                    </li>
    
                    <li>
                    <div class="RelatedStory">
                        <a title="23andMe Seeks FDA Approval for Health Report on Single Condition" href="/BioIT_Article.aspx?id=139285">23andMe Seeks FDA Approval for Health Report on Single Condition</a> | Jun 20, 2014
                    </div>
                    </li>
    
                </ul>
                </div>
            </div>
        </div>
    </div>
    

                        <br />
                        <div style="clear: both; padding-bottom: 0.5em;">
                        </div>
                        <div class="ad">
                            <div class="AdButton1">
                                
                                
                            </div>
                        </div>
                        <div class="ad">
                            <div class="AdButton2">
                                
                                
                            </div>
                        </div>
                        <div class="ad">
                            <div class="AdButton3">
                                
                                
                            </div>
                        </div>
                        <div class="ad">
                            <div class="AdButton4">
                                
                                
                            </div>
                        </div>
                        <div class="ad">
                            <div class="AdButton5">
                                
                                
                            </div>
                        </div>
                    </div>
                </td>
                <!--End Left Column Content -->
                <td class="ContentDiv">
                </td>
                <!--Middle Column Content -->
                <td class="SubbioitContentMiddle">
                    <div>
                        <div class="floatleft">
                            <div>
                                <div class="taskiconsmid NoPrint">
                                    <div class="taskiconsiconmid">
                                        
<div style="float: right">
    <table>
        <tr>
            <td class="digg_bookmark" style="vertical-align: top;">
                <script type="text/javascript" src="http://platform.linkedin.com/in.js"></script>
                <script type="in/share"  data-url="http://www.bio-itworld.com/news/02/17/12/oxford-strikes-first-in-dna-sequencing-nanopore-wars.html"></script>
            </td>
            <td class="digg_bookmark" style="vertical-align: top;">
                <a href="https://twitter.com/share" data-url="http://www.bio-itworld.com/news/02/17/12/oxford-strikes-first-in-dna-sequencing-nanopore-wars.html" class="twitter-share-button" data-lang="en" data-count="none" /><script>    !function (d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (!d.getElementById(id)) { js = d.createElement(s); js.id = id; js.src = "//platform.twitter.com/widgets.js"; fjs.parentNode.insertBefore(js, fjs); } } (document, "script", "twitter-wjs");</script>
            </td>
            <td class="digg_bookmark" style="vertical-align: top;">
                <iframe src="http://www.facebook.com/plugins/like.php?href=http%3a%2f%2fwww.bio-itworld.com%2fnews%2f02%2f17%2f12%2foxford-strikes-first-in-dna-sequencing-nanopore-wars.html&amp;layout=standard&amp;show_faces=false&amp;width=45px&amp;action=like&amp;font=arial&amp;colorscheme=light&amp;height=20px" scrolling="no" frameborder="0" style="border:none; overflow:hidden; width:45px; height:20px;" allowTransparency="true"></iframe>
            </td>
            <td style="vertical-align: top;">
                <a href="http://www.addthis.com/bookmark.php?v=250&amp;pubid=xa-4d6e8e5b235f3422"
                    class="addthis_button_compact">
                    <img src="/Workarea/images/application/bookmarks/addthis.gif" alt="" width="18px"
                        height="18px" /></a>
                <script type="text/javascript" src="http://s7.addthis.com/js/250/addthis_widget.js#pubid=xa-4d6e8e5b235f3422"></script>
            </td>
        </tr>
    </table>
</div>
<br style="clear:both" />

                                    </div>
                                </div>
                                <div class="TextHeaderline">
                                    <div class="TextHeadertext">
                                        <div class="maroonheader lgtext">
                                            
    <div class="ContentTitle"><h1>Oxford Strikes First in DNA Sequencing Nanopore Wars</h1></div>

                                        </div>
                                    </div>
                                </div>
                                <br />
                                
    
    <div class="IMUAd">
        <!-- IMU -->
        <div class="AdIMU">
              
        </div>
    </div>
    
    <div id="ctl00_ctl00_cphContent_cphContent_ContentBlock_MainContent">
	<p><font face="Arial"><font size="2"><strong>By Kevin Davies </strong></font></font> </p>
<p><font face="Arial"><font size="2"><strong>February 17, 2012 |</strong> Breaking a near total vow of silence after three years in stealth mode, Oxford Nanopore has offered stunning details of its nanopore next-generation sequencing (NGS) technology to a packed house at the premier genome sequencing conference in Marco Island, Florida. </font></font> </p>
<p><font face="Arial"><font size="2">In a talk at the Advances in Genome Biology and Technology conference this morning, <a title="chief technology officer Clive Brown " href="http://www.bio-itworld.com/NGS-Brown.html">chief technology officer Clive Brown </a>presented details of what the British company calls its “new generation” of single-strand sequencing technology, featuring accurate long reads of single-stranded DNA molecules, including the completion of two viral genomes. </font></font> </p>
<p><font face="Arial"><font size="2">In the second half of this year, the company will commercially release its previously announced GridION instrument, or node, as well as the world’s smallest DNA sequencing instrument – a portable cartridge called the MinION that doubles (and works as) a USB drive. </font></font> <font face="Arial"><font size="2"> <table align="left" cellspacing="10" cellpadding="10">
<tbody>
<tr>
<td><img title="Kevin_Davies" align="left" alt="Kevin_Davies" src="/uploadedImages/Bio-IT_World/Top_Headlines/2012/02-Feb/OxfordNanopore_AGBT.jpg" border="0" vspace="6" hspace="6" /> </td>
<td> </td>
</tr>
<tr>
<td> <span><em>Oxford Nanopore’s disruptive MinION USB device</em></span> </td>
<td> </td>
</tr>
</tbody>
</table>
<p>And in a presentation that only briefly indulged in marketing hype, Brown laid out the prospect of achieving the $1,000 genome in 2013 in under an hour by harnessing 20 GridION nodes working with a second-generation nanopore array. </p>
</font></font></p>
<p> </p>
<p> </p>
<p>And in a presentation that only briefly indulged in marketing hype, Brown laid out the prospect of achieving the $1,000 genome in 2013 in under an hour by harnessing 20 GridION nodes working with a second-generation nanopore array.   </p>
<p><font face="Arial"><font size="2">Brown and Oxford Nanopore CEO Gordon Sanghera gave <em>Bio-IT World </em>a preview of today’s announcement earlier this week. Among the system’s notable features are: </font></font> </p>
<li><font face="Arial"><font size="2">Long uninterrupted read lengths of uniform accuracy from beginning to end </font></font> </li>
<li><font face="Arial"><font size="2"><span><span><span></span></span></span>Arrays featuring 2,000 bespoke nanopores in a proprietary polymer bilayer coupled with a custom processive enzyme that ratchets the DNA template through the pore one base at a time </font></font> </li>
<li><font face="Arial"><font size="2"><span><span><span></span></span></span>An informatics system that reads overlapping nucleotide triplets in the middle of the pore to deduce the sequence </font></font> </li>
<li><font face="Arial"><font size="2"><span><span><span></span></span></span>The prospect of a sub-60-minute human genome in 2013 by networking 20 GridION nodes in unison. </font></font> </li>
<p><font face="Arial"><font size="2">By sequencing long single strands with high (if not yet perfect) accuracy, competitive cost and minimal sample prep, Oxford has taken a giant leap not only in the nanopore wars but also the entire NGS field. </font></font> </p>
<p> <font face="Arial"><font size="2">“When we sat down to design the system four years ago, I said we have to compete on every factor,” says Brown. “If we get half of them [sorted], we’ll win. And we’ve actually got almost all of them… Too many companies try to compete on one differentiator and they often fall short. We’ve tried to compete on every differentiator – a deliberate choice on our part.” </font></font> </p>
<p><font face="Arial"><font size="2">But Brown and colleagues are not basking in celebration just yet. Asked if he was impressed or satisfied with the progress his team has made over the past 1-2 years, Brown stated: “There’s no jubilation from me – this is just a starting point, not the end point. It’s the next year that matters,” referring to the early access program about to get under way, followed by commercial launch later this year. </font></font> </p>
<p><em><font face="Arial" size="2">[Editor's Note: Clive Brown will present the latest on Oxford Nanopore's sequencing platform at the <a title="inaugural Bio-IT World Asia conference in Singapore " href="http://www.bio-itworldasia.com">inaugural Bio-IT World Asia conference in Singapore </a>this June.]</font></em> </p>
<p><font face="Arial"><font size="2"><strong>The Basics</strong> </font></font> </p>
<p><font face="Arial"><font size="2"><img title="Clive Brown, Oxford Nanopore CTO" align="right" alt="Clive Brown, Oxford Nanopore CTO" src="/uploadedImages/Bio-IT_World/Top_Headlines/2012/02-Feb/Clive_Brown.jpg" border="0" vspace="6" hspace="6" />Since the mid 1990s, nanopores – natural bacterial proteins that punch holes in cell membranes – have shown immense potential for DNA sequencing and a plethora of other biological sensing applications. Oxford Nanopore was founded by Oxford University chemist professor Hagan Bayley, an authority in nanopore biochemistry.  </font></font> </p>
<p><font face="Arial"><font size="2">In 2009, <a title="Oxford Nanopore researchers published a landmark paper " href="http://www.bio-itworld.com/news/02/22/09/oxford-nanopore-DNA-sequencing-system.html">Oxford Nanopore researchers published a landmark paper </a>describing the ability of a natural nanopore to discriminate the four nucleotides in DNA by measuring electrical current blockage, providing the basis for a sequencing strategy involving an exonuclease to cleave individual bases of a DNA template that would fall into the pore to be detected. <a title="Illumina invested in the UK company" href="http://www.bio-itworld.com/news/2009/01/12/oxford-nanopore-sequencing-deal-Illumina.html">Illumina invested in the UK company</a>, becoming a minority shareholder. </font></font> </p>
<p><font face="Arial"><font size="2">But in the past 12-18 months, advances in single-strand DNA sequencing, some coming from academic collaborators such as Mark Akeson, <span>professor and chair of biomolecular engineering at the University of California, Santa Cruz, </span>offered a more rapid route to commercialization. A key factor was to complex an enzyme with the nanopore to harness and control the speed of the DNA strand as it traverses the pore. “Akeson provided the proof-of-concept, we really picked up on that,” says Brown. “Once we’d replicated that, everything after that has been completely Oxford Nanopore.” </font></font> </p>
<p><font face="Arial"><font size="2">A year ago, Oxford Nanopore <a title="released details of its GridION instrument, or node" href="http://www.bio-itworld.com/news/01/28/11/Oxford-Nanopore-GridION-system.html">released details of its GridION instrument, or node</a>, but said no more publicly about its research progress. Brown espoused the same fixed focus ten years ago while at Solexa, the British NGS company acquired by Illumina in 2007.  </font></font> </p>
<p><font face="Arial"><font size="2">Over the past 18 months, <a title="Oxford scientists led by John Milton " href="http://www.bio-itworld.com/LSW/John-Milton-Oxford-Nanopore.html">Oxford scientists led by John Milton </a>studied hundreds of nanopores for optimal properties from about a dozen porin families, including some 300 in detail. “We have a great pipeline for cloning, expressing and mutating nanopores,” says Brown. </font></font> </p>
<p><font face="Arial"><font size="2">The company settled on a custom engineered, rather than a wild-type protein. “We’re not using the academic system,” says Brown. “People tend to assume that’s what we’re doing, we’re not. We found our own nanopore and our own enzymes.” </font></font> </p>
<p><font face="Arial"><font size="2">Indeed, Oxford is also using a special enzyme to process the DNA, not the DNA polymerases currently used by some academic teams. (Brown would not disclose the identity of the enzyme.) The enzyme is capable of ratcheting DNA through the pore at upwards of 1,000 bases/second, a rate that is controlled by various cofactors in solution. The company is currently settling around 20-400 bases/second. </font></font> </p>
<p><font face="Arial"><font size="2">The bilayer membrane is also a synthetic proprietary polymer, rather than a natural lipid bilayer. This gives Oxford “incredibly robust bilayers,” says Brown, allowing the company to use biological samples (for example raw blood) that would normally destroy a natural bilayer. “So we can look at very dirty samples,” he says, including sewage-tainted river water running near the company’s lab on the outskirts of Oxford. </font></font> </p>
<p><font face="Arial"><font size="2">The first array chip, available later this year, contains 2,000 nanopores (2k). An 8,000-nanopore array (8k) is planned for release in 2013. </font></font> </p>
<p><font face="Arial"><font size="2"><strong>Going Viral</strong> </font></font> </p>
<p><font face="Arial"><font size="2">Rather than laying DNA on a solid substrate, the Oxford Nanopore system works in solution. Each of the arrayed nanopores independently grabs a DNA strand in real time. “The pore sucks [the DNA] through like spaghetti, with no degradation of signal,” says Brown. “The signal at the first base is same as the last base.” </font></font> </p>
<p><font face="Arial"><font size="2">Brown presented results of two viral sequencing efforts. The first was “an old friend, not a particularly glamorous genome” – PhiX174 – the first genome assembled by Brown and colleagues at Solexa a decade ago (and the first organism ever sequenced, by Fred Sanger in the 1970s).  </font></font> </p>
<p><font face="Arial"><font size="2">Unlike his time at Solexa, when Brown issued an email to senior management proclaiming “We’ve done it!” when the first virus was sequenced, Oxford’s achievement was “very incremental.” “We’ve had long reads for a while,” he says. “There wasn’t really a eureka moment as such that I can pinpoint.” </font></font> </p>
<p><font face="Arial"><font size="2">The Oxford Nanopore system comfortably handles the entire genome in a single read. By engineering a hairpin at the end of the molecule, both strands of the template DNA can be sequenced in succession on the same pore.  </font></font> </p>
<p><font face="Arial"><font size="2">From there, Brown’s team went onto sequence the genome of bacteriophage lambda, about ten times larger, around 48 kilobases. Again, the pores could sequence the entire linearized phage genome in a single run. “Up to 100-kilobase reads have been accomplished on the platform, that’s not exceptional,” says Brown. </font></font> </p>
<p><font face="Arial"><font size="2">Brown puts the raw error read rate at 4%, which he views as satisfactory for the time being, but because of the throughput and large read lengths, there is a “massive consensus” on the final sequence. Future improvements in accuracy are likely to emerge from improvements in engineering and sample prep methods. </font></font> </p>
<p><font face="Arial"><font size="2">“We know what causes errors – a defect inside the pore causes a bit of noise,” says Brown candidly. “Going forward, we’ll just engineer the pore to remove that noise. An incremental improvement in pore development should take us to a lower noise system.” </font></font> </p>
<p><font face="Arial"><font size="2">Most of the errors tend to be deletions, which won’t significantly affect alignment or assembly, because they will leave a gap where the bases were. Sequencing homopolymers – a major issue in some NGS platforms – also doesn’t appear to be a major issue, in part because Brown says the enzyme that processes the DNA has what he terms a “movement tick,” providing a built-in counter of sorts.  </font></font> </p>
<p><font face="Arial"><font size="2">A key feature of the system is that there is no degradation in read quality from beginning to end of the fragment, unlike most other commercial systems, where there is a decay in quality scores towards the end of each individual read length. </font></font> </p>
<p><font face="Arial"><font size="2">Brown also touched on additional features including RNA sequencing and detection of epigenetic modifications in DNA, but details on those aspects will follow later. </font></font> </p>
<p><font face="Arial"><font size="2"><strong>Informatics Issues</strong> </font></font> </p>
<p><font face="Arial"><font size="2">At the heart of the informatics processing in the Oxford system is an ASIC (application-specific integrated circuit). A vital component, says Brown, was to design “a sensor chip that does electronic readout” in order to produce parallel sensing on a sufficient scale and high quality. “You’ve got to make a custom chip. They must be designed from scratch.” </font></font> </p>
<p><font face="Arial"><font size="2">This serves as a low-noise amplifier, a digital-to-analogue convertor on a parallel chip that sits underneath the biological chip -- a series of wells covered with the polymer bilayer, into which the pores are assembled.  </font></font> </p>
<p><font face="Arial"><font size="2">The actual bioinformatics around decoding the sequence is not, as many had anticipated, detecting individual bases in the center of the pore. “What everyone has been striving for is single-base resolution,” says Brown. “We figured out you don’t need to do that.” </font></font> </p>
<p><font face="Arial"><font size="2">Brown’s group has opted to read successive Kmers in which K is a triplet. (The signal block could range from 3 to 11 bases, depending on the pore.) As the enzyme unidirectionally moves the DNA strand one base at a time, the current corresponding to each overlapping Kmer, or 3mer, is read.  </font></font> </p>
<p><font face="Arial"><font size="2">The signal processing technique involves a Hidden Markov model and a Viterbi parse finder. It’s a classic informatics strategy used in chess programs, says Brown. “We calculate the [possible] paths and condense out the base calls.”  </font></font> </p>
<p><font face="Arial"><font size="2">While Brown doesn’t rule out a single-base reading system, he says, “There’s a fair chance that single-base resolution reading (a) might be a long way off and (b) might never be better than [the current system].” On the other hand, reading longer Kmers might be better, but may not be a necessity. </font></font> </p>
<p><font face="Arial"><font size="2">The sequence is produced as a streaming fastQ file. “All software issues are dealt with on the instrument, and we do the bioinformatics -- alignment and assembly -- in real time, instead of waiting for the end of run.” </font></font> </p>
<p><font face="Arial"><font size="2">Oxford has a previously announced collaboration with Accelrys and helped develop an NGS application for its popular Pipeline Pilot software.  </font></font> </p>
<p><font face="Arial"><font size="2"><strong>Sequencing on a Stick</strong> </font></font> </p>
<p><font face="Arial"><font size="2">Perhaps the biggest surprise in today’s announcement is the creation of a sequencing device so small it actually doubles as a USB stick. It will retail for less than $900, and should pro competitive with Illumina’s MiSeq and Ion Torrent’s PGM instrument.  </font></font> </p>
<p><font face="Arial"><font size="2">“The minION breakthrough means we can premake the bilayer in the factory, put the pores in. Then you’ve got a shippable system,” says Brown.  </font></font> </p>
<p><font face="Arial"><font size="2">The memory-stick sized sequencer contains one ASIC and 512 channels, capable of producing about 120 megabases sequence per hour. The device literally plugs into a USB port on a laptop or desktop.  </font></font> </p>
<p><font face="Arial"><font size="2">“You just pipette the sample in, using a Gilson pipette -- your thumb is the pump,” says Brown. Once the sample has been loaded, sequencing beings. An app on the computer drives the device, once again producing streaming fastQ files in real time. The reads are picked up by Pipeline Pilot in a premade workflow.<span>  </span> </font></font> </p>
<p><font face="Arial"><font size="2">“You can look for things in real time,” says Brown. If the power is shut off, the sequencing reactions stop. An experiment can be suspended, the sample recovered, treated in some manner, and sequencing restarted. </font></font> </p>
<p><font face="Arial"><font size="2">“The whole workflow is completely accessible to any scientist,” says Brown. “You can put your arms around the entire problem, without having to hand off to library prep groups and cluster growers and machine runners and bioinformaticians. You can put your arms around the whole problem.” </font></font> </p>
<p><font face="Arial"><font size="2">Because the minION is small and sealable, it is ideal to be taken out on the road. All that is required is input of DNA with an overhang. Brown sees a host of potential applications from developing countries to the battlefield, environmental monitoring to educational teaching. </font></font> </p>
<p><font face="Arial"><font size="2"><strong>Price &amp; Performance</strong> </font></font> </p>
<p><font face="Arial"><font size="2">Oxford is not announcing a price for the GridION node itself, but will offer five different price bundles, in which the cost/Gb “will be competitive to current incumbent offerings,” according to CEO Gordon Sanghera. The goal is to provide flexibility to meet customer needs, depending on whether for example they prefer to minimize capital expenditures and pay for service, or a willing to pay higher prices for sequencing without so much upfront capital investment.  </font></font> </p>
<p><font face="Arial"><font size="2">“We want to leverage the way you price a mobile phone,” says Sanghera. Some customers prefer a service plan, others prefer lower upfront costs and to pay as they go. “We’ll show transparent pricing on all our products,” says Sanghera. “All customers will be treated equally.” </font></font> </p>
<p><font face="Arial"><font size="2">The price guidance for the 2k array is $25-40/Gb; the 8k array (in 2013) around $25-30/Gb. The MinION will cost $500-900/single use. “The MinION is a fantastic extrapolation of scalability,” says Sanghera.  </font></font> </p>
<p><font face="Arial"><font size="2">Oxford Nanopore is banking on requiring only a modest engineering field force or sales force. Most of the ordering and fulfillment will he handled online.  </font></font> </p>
<p><font face="Arial"><font size="2">In terms of performance, Oxford says that the cost/base for the GridION will be competitive to Illumina’s HiSeq, and has the potential to reach the $1,000 genome in under an hour by 2013.  </font></font> </p>
<p><font face="Arial"><font size="2">Throughput scales with the number of pores X the speed of sequencing X the time of the run. A network of 20 GridION nodes running the 8k arrays at 300 bases/second could in principle deliver 43 Gigabases sequence in 15 minutes, or a $1,000 genome in under an hour. (The company says the sequence will cost less than $10/Gb.)  </font></font> </p>
<p><font face="Arial"><font size="2">How many GridIONs can be networked together? Brown says there will be a practical limit, <span> </span>but “it’s a fairly big number. All the data reduction is done on board. Because [the dataare ] streamed, it’s very non-lumpy I/O. Your cluster disk storage will like it a lot, because there’s no ‘lumpiness’ in the I/O sense.” </font></font> </p>
<p><font face="Arial"><font size="2">With a path to high-throughput, single-molecule sequencing with ultra-long reads, good accuracy, low costs, and easy sample prep, Oxford’s announcement raises the stakes for many other nanopore sequencing companies, including NABsys, <a title="Genia Technologies" href="http://www.bio-itworld.com/news/10/21/11/Genia-nanopore-microchip-technology-gains-Life-Technologies-support.html">Genia Technologies</a>, and NobleGen – if not the entire NGS field.  </font></font> </p>
<p><font face="Arial"><font size="2">“Some of them are blatantly copying us, and some have wacky ideas that I don’t understand,” says Brown. “As Gordon [Sanghera] says, the nanopore war is about to start. There’ll be a lot of shouting and grandstanding in the next few months. But in my view, it’s like Solexa: we just have to get on with it. Credibility comes from experience in the field. That’s what we have to crack next.” </font></font> </p>
<p><font face="Arial" size="2"> </font> </p>
,
</div>
    <div class="Subbioittalkback">
        

            <a href="/BioIT/Login.aspx" class="Bio_ITLogInLink">Click here to login and 
            leave a comment.</a> 
        &nbsp;
        <div id="ctl00_ctl00_cphContent_cphContent_MessageBoard1">
	
<div class="ContributionForm">
<h4>
0 Comments
</h4>

<div id="EkMessageBoardInputctl00_ctl00_cphContent_cphContent_MessageBoard1" class="AddComment">

<h4>Add Comment</h4>

<p>

<textarea id="ContributionTextctl00_ctl00_cphContent_cphContent_MessageBoard1"  name="ContributionTextctl00_ctl00_cphContent_cphContent_MessageBoard1" class="ContributionText" rows="0" cols="0"></textarea>

</p>

<h6>Text Only 2000 character limit</h6>

<input type="button" id="AddCommentBtn" value="Add Comment" onclick= " _CommentValidatectl00_ctl00_cphContent_cphContent_MessageBoard1('ctl00_ctl00_cphContent_cphContent_MessageBoard1','control=ctl00_ctl00_cphContent_cphContent_MessageBoard1&amp;__ecmmsgactionctl00_ctl00_cphContent_cphContent_MessageBoard1=savemessage');return false;" />

</div>


</div>

<div class="ekMessagePaging">
<h4>Page&nbsp;1&nbsp;of&nbsp;1</h4>

<div class="ekPageControl">

</div>
</div>
<input name="ctl00$ctl00$cphContent$cphContent$MessageBoard1$ctl00$ctl00$cphContent$cphContent$MessageBoard1EktronClientManager" type="hidden" id="ctl00_ctl00_cphContent_cphContent_MessageBoard1_ctl00_ctl00_cphContent_cphContent_MessageBoard1EktronClientManager" value="AjaxScript,EktronMessageBoardJs,EktronJS" /><script id="ctl00_ctl00_cphContent_cphContent_MessageBoard1EktronScriptBlock" type="text/javascript"><!--//--><![CDATA[//><!--
	
                                        Ektron.ready(function(event, eventName)
                                        {
	Ektron.MessageBoard.Init('ctl00_ctl00_cphContent_cphContent_MessageBoard1', 'Comment', 'Text Only 2000 character limit', 'Cancel', 'Reply');Ektron.MessageBoard.replyAlertresource='Reply text is required.'
if ("undefined" == typeof window._LoadMessageBoardctl00_ctl00_cphContent_cphContent_MessageBoard1){ window._LoadMessageBoardctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._DeleteMessageEntryctl00_ctl00_cphContent_cphContent_MessageBoard1){window._DeleteMessageEntryctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){var answer ="";answer=confirm("Are you sure you want to delete this comment?");if(answer){var pageIndx="1";if (document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex") != null ) {pageIndx = document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex").value; args=args+"&__ecmcurrentpage="+pageIndx; }args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)} else {return false;}}}
if ("undefined" == typeof window._ShowMessageBoardctl00_ctl00_cphContent_cphContent_MessageBoard1){window._ShowMessageBoardctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
  if ("undefined" == typeof window._GoBackctl00_ctl00_cphContent_cphContent_MessageBoard1){window._GoBackctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._ApproveMessageEntryctl00_ctl00_cphContent_cphContent_MessageBoard1){window._ApproveMessageEntryctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._CommentValidatectl00_ctl00_cphContent_cphContent_MessageBoard1){window._CommentValidatectl00_ctl00_cphContent_cphContent_MessageBoard1 = function(uniqueid,context){var sName = 'ContributionText' + uniqueid;var iNameLen=document.getElementById(sName).value;if(iNameLen.length>0){var bAddComment = document.getElementById("AddCommentBtn");bAddComment.disabled=true;_LoadMessageBoardctl00_ctl00_cphContent_cphContent_MessageBoard1(IAjax.getArguements(),context);}else{alert("A comment text is required.");return false;}}}
 if ("undefined" == typeof window._GetReplyMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1){window._GetReplyMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){$ektron('.ekMsgBoardReplyText').empty();var pageIndx="1";if (document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex") != null ) {pageIndx = document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex").value; args=args+"&__ecmcurrentpage="+pageIndx; }args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._PostReplyMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1){window._PostReplyMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){var pageIndx="1";if (document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex") != null ) {pageIndx = document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex").value; args=args+"&__ecmcurrentpage="+pageIndx; }args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._CloseReplyMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1){window._CloseReplyMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){var pageIndx="1";if (document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex") != null ) {pageIndx = document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex").value; args=args+"&__ecmcurrentpage="+pageIndx; }args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._LoadApproveTabMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1){window._LoadApproveTabMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context) {args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._SelectApproveTabMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1){window._SelectApproveTabMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1 = function(args,context){var pageIndx="1";if (document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex") != null ) {pageIndx = document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex").value; args=args+"&__ecmcurrentpage="+pageIndx; }args=context+"&"+args;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}
 if ("undefined" == typeof window._ApproveMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1){window._ApproveMessagesctl00_ctl00_cphContent_cphContent_MessageBoard1= function (args,context) { var pageIndx="1";if (document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex") != null ) {pageIndx = document.getElementById("ctl00_ctl00_cphContent_cphContent_MessageBoard1_pageindex").value; args=args+"&__ecmcurrentpage="+pageIndx; };var approveList = ''; var e=document.getElementsByTagName("input");for(var i=0; i < e.length; i++) { if (e[i].type == "checkbox" && e[i].checked == true && e[i].id.indexOf("ctl00_ctl00_cphContent_cphContent_MessageBoard1_chkApproveMsg") == 0){if (approveList == "") { approveList = e[i].id; } else { approveList = approveList + "," + e[i].id; }}};if(approveList == ""){alert('Please select a message to approve.');}else{args=context+"&"+args+"&_itemlist="+approveList;WebForm_DoCallback('ctl00$ctl00$cphContent$cphContent$MessageBoard1',args,IAjax.DisplayResult,context,IAjax.DisplayError,false)}}} 


	
                                        });
                                  
	//--><!]]>
	</script>
</div>

    </div>


                            </div>
                        </div>
                    </div>
                    <div>
                        
                    </div>
                </td>
                <!--End Middle Column Content -->
                <td class="ContentDiv">
                </td>
                <!--Right Column Content -->
                <td class="subbioitContentRight NoPrint">
                    <div class="subbioitcontentboxrt">
                        
    
   

                        <br />
                        <div class="ad">
                            <!-- This is the skyscraper tag -->
                            <div class="AdSky">
                            </div>
                        </div>
                    </div>
                </td>
                <!--End Right Column Content -->
            </tr>
        </table>
    </div>
    <div class="Divider">
    </div>

        <!-- End Content-->
        <!-- End Content-->
        <div class="footeradbannertop NoPrint">
            <!-- This is the leaderboard tag for Bio-it -->
            <div class="BottomAdRight">
                
            </div>
            <div class="AdLeaderBoardBottom">
                
            </div>
        </div>
        <div class="fotteradbannernav">
            <div id="ctl00_ctl00_ContentBlock_FooterReprint">
	<p><font color="#000000">For reprints and/or copyright permission, please contact&#160;</font><font color="#000000"> Terry Manning, 781.972.1349 ,</font>&#160;<a href="mailto:tmanning@healthtech.com">tmanning@healthtech.com</a><font color="#000000">.</font>&#160;</p>
</div>
        </div>
    </div>
    <!-- Footer-->
    <!--Content-->
    <div id="footerContainer">
        <div id="ctl00_ctl00_ContentBlock_footer">
	<div id="footerwrapper"><div id="contactInfo"><a class="chiLogo" href="http://www.chicorporate.com"></a><p>250 First Avenue Suite 300<br />Needham, MA 02494<br />P: 781.972.5400<br />F: 781.972.5425<br />E: <a href="mailto:chi@healthtech.com">chi@healthtech.com</a><br />&#160;</p>
</div>
<div id="portals"><div class="FooterSectionTitle"><strong>life science portals</strong>&#160;</div>
<div id="portalsLeftColumn"><p><a href="http://biologicaltherapeutics.chicorporate.com/">biological therapeutic products</a><br /><a href="http://biomarkers.chicorporate.com/">biomarkers &amp; diagnostics</a><br /><a href="http://biopharmastrategy.chicorporate.com/">biopharma strategy</a><br /><a href="http://bioprocessing.chicorporate.com/">bioprocess &amp; manufacturing</a><br /><a href="http://chemistry.chicorporate.com/">chemistry</a><br /><a href="http://clinicaltrials.chicorporate.com/">clinical trials &amp; translational medicine</a><br /><a href="http://druganddevice.chicorporate.com/">drug &amp; device safety</a><br />&#160;</p>
</div>
<div id="portalsRightColumn"><p><a href="http://drugdevelopment.chicorporate.com/">drug discovery &amp; development</a><br /><a href="http://drugtargets.chicorporate.com/">drug targets</a><br /><a href="http://genomics.chicorporate.com/">genomics</a><br /><a href="http://healthcare.chicorporate.com/">healthcare</a><br /><a href="http://it.chicorporate.com/">it &amp; informatics</a><br /><a href="http://techtools.chicorporate.com/">technology &amp; tools for life science</a><br /><a href="http://therapeutics.chicorporate.com/">therapeutic indications</a><br />&#160;</p>
</div>
</div>
<div id="divisions"><div class="FooterSectionTitle"><strong>chi divisions</strong>&#160;</div>
<p><a href="http://www.healthtech.com/">conferences</a><br /><a href="http://www.insightpharmareports.com/">reports</a><br /><a href="http://www.barnettinternational.com/">barnett educational services</a><br /><a href="http://www.chacorporate.com/">consulting</a><br /><a href="http://www.chimediagroup.com/">publications &amp; <span class="lc">e</span>Newsletters</a><br /><a href="http://www.knowledgefoundation.com">Knowledge Foundation </a><br /><a href="http://proservices.healthtech.com/">professional services</a><br />&#160;</p>
</div>
<div id="mainLinks"><p><a href="http://www.chicorporate.com/executive_team">executive team</a><br /><a href="http://www.chicorporate.com/corporate_pages.aspx?id=108787">testimonials</a><br /><a href="http://www.chicorporate.com/corporate_pages.aspx?id=46">chi timeline</a><br /><a href="http://www.healthtech.com/mailinglist.aspx">mailing list</a><br /><a href="/careers/">careers</a>&#160;</p>
<div class="hr" id="hr"><hr />



&#160;</div>
<p><a href="http://www.chicorporate.com/Corporate/RequestInformation.aspx">request information</a><br /><a href="http://www.chicorporate.com/Corporate_Content.aspx?id=86330">site map</a><br /><a href="http://www.chicorporate.com/calendars/elearning">eLearning Calendar</a><br /><a href="http://www.chicorporate.com/Corporate/PrivacyPolicy.aspx">privacy policy</a><br />&#160;</p>
</div>
</div>
</div>
    </div>
    <!--End Footer-->
    

<script type="text/javascript">
//<![CDATA[
(function() {var fn = function() {$get("ctl00_ctl00_ScriptManager1_HiddenField").value = '';Sys.Application.remove_init(fn);};Sys.Application.add_init(fn);})();Sys.Application.initialize();
//]]>
</script>
</form>
    <script language="javascript" type="text/javascript" src="/javascript/EktronFixes.js"></script>
    <script type="text/javascript">

        var _gaq = _gaq || [];
        var pluginUrl =
            '//www.google-analytics.com/plugins/ga/inpage_linkid.js';
        _gaq.push(['_require', 'inpage_linkid', pluginUrl]);
        _gaq.push(['_setAccount', 'UA-912037-7']);
        _gaq.push(['_trackPageview']);

        (function () {
            var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
            ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
            var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
        })();

    </script>
    <script type="text/javascript"><!--
adroll_adv_id = "DCFZUIUXPFGEBLLKBFJIZP";
adroll_pix_id = "G7LWMIQK2RARFEUMMDTGLQ";
(function () {
var oldonload = window.onload;
window.onload = function(){
   __adroll_loaded=true;
   var scr = document.createElement("script");
   var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
   scr.setAttribute('async', 'true');
   scr.type = "text/javascript";
   scr.src = host + "/j/roundtrip.js";
   ((document.getElementsByTagName('head') || [null])[0] ||
    document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
   if(oldonload){oldonload()}};
}());
--></script>
    
</body>


    <script>
        $("#nav li ul").addClass(function (index) {
            return "subNav" + index;
        });
        $("#nav li:last").addClass("last");
    </script>

    <script type="text/javascript" src="/javascript/cbc-menu.js"></script>
     <script src="/javascript/bit/carousel.js" type="text/javascript"></script>
</html>
